ArticleArchives of dermatological research2025
Investigating the impact of perceived social stigmatization and social appearance anxiety on quality of life among patients with facial skin diseases.
Article in Archives of dermatological research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Assessment of Psychological and Social Impact on Patients Rehabilitated With Conventional and Modern Technology-Based Maxillofacial Prosthetics.International journal of dentistry · 2026Article
- Automatic aggression of future sports coaches is influenced by the presence of nevi-an exploratory study.Frontiers in psychology · 2026Article
- Article
- Impact of Vitiligo on Major Life-changing Decisions and Perceived Stigmatization: A Cross-sectional Study.Acta dermato-venereologica · 2025Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study investigates the interplay between perceived social stigmatization, social appearance anxiety, and quality of life in individuals with facial skin diseases. Furthermore, it undertakes the psychological and social impact of visible skin diseases, such as acne, atopic dermatitis, rosacea, enlarged pores, and vitiligo, on individuals' quality of life. These conditions not only cause physical discomfort but also lead to feelings of sadness, anxiety, and low self-esteem. The research aims to investigate how perceived social stigmatization and social appearance anxiety affect the well-being of individuals with facial skin diseases. By examining these factors, the study highlights the need for dermatology-tailored interventions to address the psychological and social challenges faced by this group.
methodsThis study was conducted between July to October 2023. A purposive sample (N = 250) included both men (112) and women (138) with an age range of 18 to 45 years (M = 28.01, SD = 4.65). The study utilizes standardized measures of the Perceived Social Stigmatization Questionnaire, Social Appearance Anxiety Scale, and Skin Related Quality of Life Scale, to assess the study variables. The data were collected from various hospitals and clinics in Islamabad and Rawalpindi.
resultsThe results revealed that perceived social stigmatization and social appearance anxiety negatively impact skin-related quality of life among individuals with facial skin problems. Females exhibit higher levels of these concerns compared to males, leading to a more impaired quality of life. Additionally, individuals suffering from specific skin conditions for a long time experience elevated levels of stigmatization and anxiety, further impairing their quality of life.
conclusionsThese findings highlight the significance of addressing social stigmatization and social appearance anxiety in dermatology-tailored interventions aimed at the quality of life for individuals dealing with facial skin concerns.
Indexed as
Identifiers
39775058What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.